Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01897935 · ClinicalTrials.gov registry record

Flare Photometry in Uveitis Patients

A clinical trial of Uveitis, sponsored by ChromoLogic.

Completed
Registry status
100
Enrollment target
1
Study location

NCT01897935 is a study of Uveitis that has completed, run by ChromoLogic. The registered enrollment target is 100 participants, below the 612-participant average among 19 other Uveitis trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01897935, a study of Uveitis, has completed, sponsored by ChromoLogic.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This is a cross sectional study of a novel non-invasive optical flare photometer (OFAM). Patients meeting the inclusion/exclusion criteria will receive a standard eye examination including a slit lamp examination to collect ocular flare data. In addition to the standard eye examination, subjects will receive flare measurements using the OFAM device.

Conditions Studied

Study Locations (1)

Washington

  • UW Medicine Eye Institute - Seattle

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2013-06
Est. Completion 2014-04

Sponsor

ChromoLogic

2 total trials

What the Registry Record Tells You About NCT01897935

The ClinicalTrials.gov registry entry for NCT01897935 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 612-participant average among 19 other Uveitis trials with a reported enrollment target (84% lower). The listed sponsor is ChromoLogic, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Uveitis appearing as the primary indexed condition, and to 0 interventions.

NCT01897935 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01897935 about?

NCT01897935 is a clinical study titled "Flare Photometry in Uveitis Patients". This is a cross sectional study of a novel non-invasive optical flare photometer (OFAM). Patients meeting the inclusion/exclusion criteria will receive a standard eye examination including a slit lamp examination to collect ocular flare data. In addition to the standard eye examination, subjects wil...

What is the current status of trial NCT01897935?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-06. Estimated completion is 2014-04.

What conditions does trial NCT01897935 study?

This clinical trial studies the following conditions: Uveitis.

Who is sponsoring clinical trial NCT01897935?

This trial is sponsored by ChromoLogic, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01897935 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Uveitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.